Edict Pharmaceuticals Pvt. Ltd., Par Pharmaceutical deal

Par will acquire generics company Edict for up to $37.6 million in cash. Par has also agreed to repay certain undisclosed debt. Par said the acquisition will enhance its R&D infrastructure and add ope...